Shiono Satoshi, Endo Makoto, Suzuki Katsuyuki, Yanagawa Naoki
Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Department of Pathology, Yamagata Prefectural Central Hospital, Yamagata, Japan.
J Thorac Dis. 2020 May;12(5):2247-2260. doi: 10.21037/jtd.2020.04.47.
Spread through air spaces (STAS) is reportedly a significant risk factor for recurrence and a prognostic factor in patients with non-small cell lung cancer (NSCLC), especially after sublobar resection. Because wedge resection (WR) is associated with insufficient margins, we hypothesized that STAS has a greater prognostic impact in patients who undergo WR compared with segmentectomy. We aimed to clarify the value of STAS as a prognostic factor in patients with NSCLC after WR.
We evaluated 217 patients with clinical stage IA NSCLC who underwent sublobar resection. The prognostic impact of STAS in these patients was compared between the WR (n=100) and segmentectomy (n=117) cases.
STAS was present in 15.7% of the 217 patients. STAS was a significant prognostic factor for overall survival in univariate (P<0.001) and multivariate (P=0.003) analyses for the WR cases, but not the segmentectomy cases (P=0.399). STAS was also a significant prognostic factor for freedom from recurrence in univariate (P=0.010) and multivariate (P=0.024) analyses for the WR cases, but was only marginally significant for the segmentectomy cases (P=0.050, univariate analysis). The solid tumor size on chest computed tomography was significantly related to STAS. A cut-off solid tumor size of 1.7 cm for predicting the presence of STAS was determined by receiver operating characteristic analysis.
STAS was a significant prognostic factor for patients with clinical stage IA NSCLC who underwent WR, but not those who underwent segmentectomy.
据报道,气腔播散(STAS)是非小细胞肺癌(NSCLC)患者复发的重要危险因素和预后因素,尤其是在亚肺叶切除术后。由于楔形切除术(WR)切缘不足,我们推测与肺段切除术相比,STAS对接受WR的患者预后影响更大。我们旨在阐明STAS作为WR术后NSCLC患者预后因素的价值。
我们评估了217例接受亚肺叶切除的临床IA期NSCLC患者。比较了WR组(n = 100)和肺段切除组(n = 117)患者中STAS的预后影响。
217例患者中15.7%存在STAS。在单因素(P<0.001)和多因素(P = 0.003)分析中,STAS是WR病例总生存的显著预后因素,但在肺段切除病例中不是(P = 0.399)。在单因素(P = 0.010)和多因素(P = 0.024)分析中,STAS也是WR病例无复发生存的显著预后因素,但在肺段切除病例中仅边缘显著(单因素分析,P = 0.050)。胸部计算机断层扫描上的实性肿瘤大小与STAS显著相关。通过受试者工作特征分析确定预测STAS存在的实性肿瘤大小截断值为1.7 cm。
STAS是接受WR的临床IA期NSCLC患者的显著预后因素,但不是接受肺段切除术患者的显著预后因素。